about
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.Mistletoe: for cancer or just for Christmas?Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targetsMyocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosisProteome-wide dataset supporting functional study of tyrosine kinases in breast cancerThe efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer.Circulating free DNA in the management of breast cancer.Patient-derived xenografts for individualized care in advanced sarcoma.Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerWhole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodesLeptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathwayInfluence of plasma processing on recovery and analysis of circulating nucleic acids.Combined PKC and MEK inhibition for treating metastatic uveal melanomaMammosphere formation assay from human breast cancer tissues and cell lines.TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction networkmiR-515-5p controls cancer cell migration through MARK4 regulationEmerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTENIntra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy.ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation.Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies.MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?A microRNA meta-signature for pancreatic ductal adenocarcinoma.Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice.Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation.Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer.microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.Gene of the month: NANOG.Angiosarcoma and Dialysis-related Arteriovenous Fistulae: A Comprehensive Review.HOT mutation screening in human glioblastomas.Gene of the month: Axl.The need for multidisciplinarity in specialist training to optimize future patient care.Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention.The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancy.
P50
Q27692015-66716F3A-7EDA-42AA-B900-73991AD0968AQ28302713-D97120F2-AA0D-45FB-AC41-03E981C7B9CEQ28541545-86525F80-4FAC-4DA8-A48D-191BEB61FFE0Q28573405-D02D4D8A-42AC-4452-AF31-62EB7F76D671Q30489198-961F1E97-0A3A-46FB-A1EB-C0FCB2845FB5Q33418902-B2FB8366-6EEE-49BA-A98C-46371868A505Q33753780-B1FDD5A1-45EF-46B3-9ACA-E85329FB2425Q34357893-CC1F23B4-EEB7-4A3A-81EF-89406F8D0684Q34413869-C53A8D1C-5AB3-46CC-A038-C966817C560DQ34539541-21E75645-2862-495D-8DEC-49388B2CCA48Q34784863-40F0F656-47E1-4193-8960-26445AE6B16BQ35000226-A13F6826-E5E8-46F7-972E-651E357B772AQ35035846-893B6245-88D6-4152-BD35-D262B8281236Q35168515-9C123506-2840-467B-B2B3-488EA47CFDBFQ35460919-6CCD3CB1-4024-465F-A20F-72B8952B41B7Q36633192-80F11C0B-F58A-49EA-82E5-73E3212C536EQ36759535-43F2DE30-61E1-440D-ADA3-D5855E5FFBD8Q37264369-2BC79411-C3ED-437F-B037-E39179A476C8Q37308194-4ED541F9-6A80-4D93-B4FF-C36BEFD9A568Q37317337-A4035098-1BD8-450B-9DB7-3EC565990138Q37317608-3B323F6B-2AFC-44EE-8062-EF3E1AB40911Q37499806-CF2049F8-14CD-4D07-A943-B24BFE3FD296Q37594444-8B0D1A39-C28F-404C-B38B-F2DAE383257DQ37711669-2A577313-21CC-4CFD-BBE7-7DBD8849128EQ38167884-EADB0A9A-1DC8-4EBB-A3AE-F29A41B6BE5BQ38191669-B20AB172-FFD4-48D4-8181-3ADD44114962Q38201443-3209C52F-CC4A-4F49-9762-B6C077ACCFCCQ38234006-605BA115-E24E-464D-B586-B958934C2F69Q38262764-FBBA0F42-A3AA-43B2-9AB7-123BA3B39FA8Q38498940-B6D9AE02-4C1C-43CE-976D-9B765283A948Q38525755-1231E8ED-E78D-4FE2-94C1-B03034377C39Q38555813-1B456590-2A78-4C28-BA20-DF713B2DA6ADQ38611467-8C3089EC-1FB7-4B9E-ABF6-37C19793E0D3Q38747962-CF76A6E7-11CF-495A-AD1B-5F5F8734918CQ38763966-1F0C5E8F-C00E-49FD-A5C5-A94551FC8D65Q38789457-361BDFDE-C537-4423-A94B-BBC931CFCDE1Q38933493-E0E3B8DE-0325-47AC-812B-94DB457558BAQ38983568-610172A1-385E-4B5A-833D-10D566914571Q38987139-8C475363-B0B9-4A14-AAE4-9AB8894B3290Q39184012-ADF28531-BECE-4CA2-AAF5-E28228A41E25
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Justin Stebbing
@en
Justin Stebbing
@nl
type
label
Justin Stebbing
@en
Justin Stebbing
@nl
prefLabel
Justin Stebbing
@en
Justin Stebbing
@nl
P31
P496
0000-0002-1117-6947